Specific EEG markers in POLG1 Alpers’ syndrome
Authors:
- Anouk van WestrhenenAWAnouk van Westrhenen
- Elisabeth A. CatsECElisabeth A. Cats
- Bart van Den MunckhofBMBart van Den Munckhof
- Sandra M.A. van der SalmSSSandra M.A. van der Salm
- Nico W. TeunissenNTNico W. Teunissen
- Cyrille H. FerrierCFCyrille H. Ferrier
- Frans S.S. LeijtenFLFrans S.S. Leijten
- Karin P.W. GeleijnsKGKarin P.W. Geleijns
- 1 October 2018
- journal article
- research article
- Published by Elsevier in Clinical Neurophysiology
- Vol. 129 (10) , 2127-2131
Abstract
No abstract availableKeywords
This publication has 10 references indexed in Scilit:
- Epilepsy due to mutations in the mitochondrial polymerase gamma (POLG) gene: A clinical and molecular genetic reviewEpilepsia, 2016
- Alpers Syndrome With Mutations in POLG: Clinical and Investigative FeaturesPediatric Neurology, 2011
- High‐frequency oscillations as a new biomarker in epilepsyAnnals of Neurology, 2011
- The clinical diagnosis of POLG disease and other mitochondrial DNA depletion disordersMethods, 2010
- Polymerase gamma disease through the agesDevelopmental Disabilities Research Reviews, 2010
- Status epilepticus in children with Alpers’ disease caused byPOLG1mutations: EEG and MRI featuresEpilepsia, 2009
- POLG1 mutations cause a syndromic epilepsy with occipital lobe predilectionBrain, 2008
- The spectrum of clinical disease caused by the A467T and W748S POLG mutations: a study of 26 casesBrain, 2006
- Review Article: Progressive Neuronal Degeneration of Childhood With Liver Disease (Alpers-Huttenlocher Syndrome): A Personal ReviewJournal of Child Neurology, 1990
- Progressive Neuronal Degeneration of Childhood with Liver Disease("Alpers' Disease"): Characteristic Neurophysiological FeaturesNeuropediatrics, 1986